Stocktoria
CollPlant Biotechnologies Ltd CLGN
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 1993-09-01
CollPlant Biotechnologies Ltd statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 64.8% | -215.5% | 81.8% | -33.8% | 87.2% |
| Operating margin | -484.3% | -3349.7% | -68.5% | -5718.1% | 0.4% |
| Net margin | -484.6% | -3225.0% | -64.0% | -5660.5% | 1.5% |
| FCF margin | -398.4% | -2830.3% | -33.9% | -5007.4% | 6.9% |
| Return on assets | -106.5% | -88.8% | -20.6% | -44.8% | 0.5% |
| Return on equity | -188.9% | -123.3% | -24.8% | -52.4% | 0.5% |
| Debt / equity | — | — | — | — | 0.00× |
| Current ratio | 2.53 | 4.44 | 8.62 | 10.20 | 14.96 |
| Revenue growth | 360.4% | -95.3% | 3565.2% | -98.1% | 154.9% |
Source: SEC EDGAR filings · CIK 0001631487 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.